BC-7013 structure
|
Common Name | BC-7013 | ||
---|---|---|---|---|
CAS Number | 1028291-66-8 | Molecular Weight | 500.69 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C29H40O5S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of BC-7013BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1]. |
Name | BC-7013 |
---|
Description | BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1]. |
---|---|
Related Catalog | |
Target |
MIC50: 0.015µg/mL (303 tested S. aureus isolates)[2] |
References |
Molecular Formula | C29H40O5S |
---|---|
Molecular Weight | 500.69 |